SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Vivimed Labs reports 83% jump in Q4 net profit

01 Jun 2012 Evaluate

Vivimed Labs has registered an 83.16% surge in net profit to Rs 22.29 crore for the fourth quarter ended March 2012 as compared to Rs 12.17 crore during the corresponding quarter last year. The company’s net income from operations has jumped over two fold in the fourth quarter to Rs 251.96 crore during the quarter, from Rs 120.57 crore in the same period a year ago.

For the full year, the company's net profit rose 29.24% to Rs 63.13 crore from Rs 48.83 crore last year. The company’s net income for the year stood at Rs 670.99 crore, registering a growth of 60.93%, as against Rs 416.93 crore in the previous year.

Vivimed Labs Share Price

7.26 -0.38 (-4.97%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×